OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market.
OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2016 | Series Unknown | $7M | 1 | — | — | Detail |
May 19, 2015 | Series Unknown | $8M | 1 | — | — | Detail |
Jan 1, 2011 | Series A | — | 1 | — | — | Detail |
Apr 5, 2009 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Triventures | — | Series Unknown |
Fuerst Technology Innovations | — | Series A |